Approvals/TGA/FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60mcg, 0.5mL suspension for injection - 2025 season

Approved

STANDARD

FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60mcg, 0.5mL suspension for injection - 2025 season

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: 465db36f03aa82a0
Company: Sanofi-Aventis Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 465db36f03aa82a0
Product Name: FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60mcg, 0.5mL suspension for injection - 2025 season
Artg Id: 213963
Artg Name: FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60mcg, 0.5mL suspension for injection
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2014-12-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01083-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-03353-1

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

465db36f03aa82a0

Type

Standard

Back to TGA Approvals